Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids, lipoprotein subfraction concentrations, and lipoprotein composition in 30 healthy individuals. Participants (n = 30) were randomized to ANA 20 mg/day, 150 mg/day, or placebo for 2...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Krauss, Ronald M., Wojnooski, Kathleen, Orr, Joseph, Geaney, J. Casey, Pinto, Cathy Anne, Liu, Yang, Wagner, John A., Luk, Julie Mabalot, Johnson-Levonas, Amy O., Anderson, Matt S., Dansky, Hayes M.
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2012
Matèries:
Patient-Oriented and Epidemiological Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276477/
https://ncbi.nlm.nih.gov/pubmed/22180633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M018010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars